MRD assessment using EuroFlow in patients with multiple myeloma receiving KRD therapy

Takeshi Yoroidaka

Presentation information

Oral Session

Oral Session 3-15A Multiple Myeloma: Clinical (MRD/Infection)

Sun. Oct 13, 2019 9:00 AM - 10:00 AM No.15 (Tokyo International Forum, 7F G701)

Chair: Hiroyuki Takamatsu (Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University)

[OS3-15A-2] MRD assessment using EuroFlow in patients with multiple myeloma receiving KRD therapy

Takeshi Yoroidaka¹, Hiroyuki Takamatsu¹, Takeshi Yamashita², Ryoichi Murata², Kyoko Yoshihara⁴, Satoshi Yoshihara⁴, Mikio Ueda², Shinji Nakao¹, Kosei Matsue³ (1.Hematol., Kanazawa Univ., Kanazawa, Japan, 2.Keiju Kanazawa Hospital, Kanazawa, Japan, 3.Kameda Medical Center, Kamogawa, Japan, 4.Hyogo College of Medicine, Nishinomiya, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.